Diaceutics and Experian bring diagnostically informed media activation to pharma marketers
Pharmaceutical and life sciences teams can activate diagnostically informed audiences through familiar media buying workflows
Belfast, UK and New York, NY — April 21, 2026 — Diaceutics, the precision data company challenging the status quo approach to healthcare audience targeting, today announced a new collaboration with Experian, a leading global data and technology company. Through this collaboration, Diaceutics’ AI-driven diagnostic and clinical intelligence audiences are available for activation through Experian Marketing Services through a variety of channels - including onboarding to various platforms, inclusion in curated deals powered by Audigent, and in Experian’s data marketplace.
With Diaceutics’ audiences, marketers can act on more current, clinically grounded data. This enables brands to plan with greater confidence and demonstrate measurable impact across channels, while maintaining a privacy-first approach.
Making Diagnostic Intelligence Available Where It Actually Gets Activated
Healthcare marketers are rich in data. What’s often missing is a clear path for clinical and diagnostic audiences to flow into the tools used to plan, buy, and measure media. When those audiences show up in existing workflows, insight moves into activation, and performance is easier to measure. With Diaceutics audiences now live in the Experian data marketplace, and available for onboarding and Curated Deals, marketers can utilize these audiences across preferred media platforms and premium publisher environments.
“Innovation rarely fails because the data isn’t good. It fails because it doesn’t fit into how teams actually buy media,” said Scott Phillips, vice president, RealWorld Data at Diaceutics. “By integrating our diagnostically informed audiences directly into Experian’s marketplace, we’re eliminating the friction that’s historically held the industry back. Precision targeting now scales inside existing media planning strategies, accelerating adoption, usage, and measurable impact, without forcing teams to change how they operate.”
This collaboration solves the biggest commercial adoption challenge facing healthcare marketers:
- Accurate insights with off-the-shelf media buying simplicity
- Diagnostic signals that replace outdated, lagging indicators inherent in claims data
- Scale through Experian Digital Graph and existing channels
- No new tech stack, processes or buying motions required
For Diaceutics, this brings diagnostic intelligence into an established U.S. data marketplace. For media buyers, it puts diagnostically informed targeting next to standard audience segments, with fewer procurement steps and minimal custom integration.
Experian Marketing Services expands its marketplace with differentiated health audiences
Experian Marketing Services helps brands identify, understand, and activate audiences with reliable data and strong privacy standards. By adding Diaceutics’ diagnostically informed audiences, Experian Marketing Services expands its onboarding, marketplace and curation offerings, with a healthcare-focused dataset built for pharmaceutical and life sciences activation.
“Our goal is to help marketers turn data into measurable outcomes,” said Colleen Dawe, Vice President of advertiser partnerships at Experian. “Diaceutics brings diagnostically informed insight that can be hard to find in claims-based approaches. Making these audiences available through our onboarding, marketplace and curation services gives pharmaceutical and life sciences marketers fast access to differentiated audiences, without adding complexity to their workflows.”
About Diaceutics
At Diaceutics, we believe every patient should get the right test and right therapy to positively impact their outcome. For 20 years, Diaceutics has delivered precision medicine solutions to the world’s leading pharma and biotech companies, bridging the gap between diagnostic testing and targeted therapies through clinically rich, AI‑driven data.
About Experian
Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.
We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.
We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.
